Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging

The standard approach to assess hematopoietic stem cell (HSC) engraftment in experimental bone marrow transplantation models relies on detection of donor hematopoietic cells in host bone marrow following death; this approach provides data from only a single time point after transplantation for each animal. In vivo bioluminescence imaging was therefore explored as a method to gain a dynamic, longitudinal profile of human HSC engraftment in a living xenogeneic model. Luciferase expression using a lentiviral vector allowed detection of distinctly different patterns of engraftment kinetics from human CD34(+) and CD34(+)CD38(-) populations in the marrow NOD/SCID/beta2m(null) mice. Imaging showed an early peak (day 13) of engraftment from CD34(+) cells followed by a rapid decline in signal. Engraftment from the more primitive CD34(+)CD38(-) population was relatively delayed but by day 36 increased to significantly higher levels than those from CD34(+) cells (P < .05). Signal intensity from CD34(+)CD38(-)-engrafted mice continued to increase during more than 100 days of analysis. Flow cytometry analysis of bone marrow from mice after death demonstrated that levels of 1% donor cell engraftment could be readily detected by bioluminescence imaging; higher engraftment levels corresponded to higher image signal intensity. In vivo bioluminescence imaging provides a novel method to track the dynamics of engraftment of human HSC and progenitors in vivo. (C) 2003 by The American Society of Hematology.